Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 129 | 2013 | 6986 | 5.750 |
Why?
|
Delusions | 16 | 2013 | 301 | 3.750 |
Why?
|
Vitamin D Deficiency | 47 | 2014 | 1389 | 3.380 |
Why?
|
Paternal Age | 13 | 2014 | 87 | 2.760 |
Why?
|
Psychotic Disorders | 44 | 2014 | 3278 | 2.620 |
Why?
|
Dyskinesia, Drug-Induced | 16 | 2011 | 165 | 2.180 |
Why?
|
Vitamin D | 24 | 2013 | 3311 | 2.090 |
Why?
|
Seasons | 25 | 2013 | 1526 | 1.770 |
Why?
|
Schizophrenic Psychology | 20 | 2011 | 1652 | 1.640 |
Why?
|
Australia | 41 | 2014 | 1264 | 1.590 |
Why?
|
Receptors, Calcitriol | 9 | 2013 | 361 | 1.070 |
Why?
|
Mental Disorders | 18 | 2014 | 6879 | 1.040 |
Why?
|
Maternal Age | 5 | 2014 | 809 | 0.990 |
Why?
|
Prenatal Exposure Delayed Effects | 24 | 2012 | 2538 | 0.960 |
Why?
|
Antipsychotic Agents | 25 | 2012 | 3077 | 0.870 |
Why?
|
Calcifediol | 7 | 2012 | 160 | 0.830 |
Why?
|
Brain | 31 | 2012 | 27438 | 0.830 |
Why?
|
Affective Disorders, Psychotic | 4 | 2009 | 187 | 0.740 |
Why?
|
Schizophrenia, Paranoid | 2 | 2013 | 103 | 0.740 |
Why?
|
Health Surveys | 16 | 2014 | 4056 | 0.680 |
Why?
|
Marijuana Abuse | 5 | 2013 | 412 | 0.660 |
Why?
|
Research | 4 | 2013 | 1984 | 0.630 |
Why?
|
Cholecalciferol | 7 | 2013 | 557 | 0.630 |
Why?
|
Anthropometry | 4 | 2007 | 1343 | 0.620 |
Why?
|
Risk Factors | 66 | 2014 | 74915 | 0.610 |
Why?
|
Patellar Ligament | 3 | 2010 | 66 | 0.610 |
Why?
|
Psychiatric Status Rating Scales | 21 | 2013 | 6035 | 0.600 |
Why?
|
Psychoses, Substance-Induced | 2 | 2010 | 99 | 0.590 |
Why?
|
Dietary Supplements | 5 | 2013 | 3445 | 0.590 |
Why?
|
Employment | 3 | 2014 | 1120 | 0.580 |
Why?
|
Birth Weight | 4 | 2007 | 2117 | 0.580 |
Why?
|
Olfactory Mucosa | 10 | 2013 | 102 | 0.570 |
Why?
|
Behavior, Animal | 17 | 2013 | 1882 | 0.570 |
Why?
|
Queensland | 11 | 2010 | 53 | 0.570 |
Why?
|
Female | 186 | 2014 | 396943 | 0.560 |
Why?
|
Developmental Disabilities | 6 | 2013 | 1516 | 0.560 |
Why?
|
Male | 175 | 2014 | 364781 | 0.550 |
Why?
|
Child of Impaired Parents | 2 | 2012 | 463 | 0.530 |
Why?
|
Humans | 245 | 2014 | 768451 | 0.530 |
Why?
|
Vitamin E | 3 | 2011 | 873 | 0.520 |
Why?
|
Denmark | 9 | 2014 | 778 | 0.520 |
Why?
|
Cognition | 6 | 2013 | 7066 | 0.520 |
Why?
|
Hallucinations | 5 | 2010 | 375 | 0.520 |
Why?
|
Mentally Ill Persons | 3 | 2014 | 126 | 0.510 |
Why?
|
Neurons | 17 | 2011 | 9504 | 0.500 |
Why?
|
Emigrants and Immigrants | 3 | 2011 | 548 | 0.500 |
Why?
|
Sex Factors | 30 | 2014 | 10647 | 0.500 |
Why?
|
Prevalence | 29 | 2013 | 15880 | 0.490 |
Why?
|
Adolescent | 70 | 2014 | 89168 | 0.490 |
Why?
|
Cryopreservation | 4 | 2006 | 731 | 0.490 |
Why?
|
Adult | 120 | 2014 | 223542 | 0.470 |
Why?
|
Cognition Disorders | 7 | 2012 | 3985 | 0.470 |
Why?
|
Environment | 3 | 2010 | 1126 | 0.460 |
Why?
|
Dermatoglyphics | 3 | 2003 | 21 | 0.460 |
Why?
|
Pregnancy | 48 | 2013 | 30179 | 0.460 |
Why?
|
Registries | 10 | 2014 | 8373 | 0.460 |
Why?
|
Demography | 4 | 2008 | 1643 | 0.450 |
Why?
|
Sex Distribution | 10 | 2013 | 2286 | 0.440 |
Why?
|
Competitive Behavior | 1 | 2014 | 78 | 0.440 |
Why?
|
Infant, Newborn | 22 | 2012 | 26395 | 0.430 |
Why?
|
Rickets | 2 | 2012 | 70 | 0.430 |
Why?
|
Body Height | 3 | 2009 | 1568 | 0.430 |
Why?
|
25-Hydroxyvitamin D 2 | 2 | 2012 | 40 | 0.430 |
Why?
|
Family | 5 | 2013 | 3208 | 0.420 |
Why?
|
Birth Rate | 4 | 2003 | 168 | 0.420 |
Why?
|
Cytoskeleton | 3 | 2006 | 1179 | 0.420 |
Why?
|
Salts | 1 | 2012 | 62 | 0.410 |
Why?
|
Anions | 1 | 2012 | 138 | 0.410 |
Why?
|
Urban Population | 6 | 2010 | 2047 | 0.410 |
Why?
|
Cross-Cultural Comparison | 7 | 2012 | 639 | 0.400 |
Why?
|
Fetal Development | 4 | 2011 | 771 | 0.400 |
Why?
|
Cell Cycle | 6 | 2011 | 2942 | 0.400 |
Why?
|
Motor Activity | 14 | 2013 | 2722 | 0.400 |
Why?
|
Nerve Tissue Proteins | 7 | 2011 | 4417 | 0.390 |
Why?
|
Cannabis | 3 | 2013 | 444 | 0.370 |
Why?
|
Incidence | 22 | 2014 | 21552 | 0.370 |
Why?
|
Focal Adhesions | 2 | 2013 | 114 | 0.370 |
Why?
|
Neurotransmitter Agents | 3 | 2011 | 666 | 0.370 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 371 | 0.360 |
Why?
|
Age Factors | 28 | 2014 | 18478 | 0.360 |
Why?
|
Osteoblasts | 2 | 2006 | 1154 | 0.360 |
Why?
|
Educational Status | 3 | 2013 | 2519 | 0.350 |
Why?
|
Developmental Biology | 1 | 2011 | 79 | 0.350 |
Why?
|
Epidemiologic Studies | 4 | 2008 | 681 | 0.350 |
Why?
|
Young Adult | 37 | 2014 | 60045 | 0.350 |
Why?
|
Object Attachment | 1 | 2013 | 333 | 0.350 |
Why?
|
Growth | 1 | 2012 | 366 | 0.340 |
Why?
|
Middle Aged | 89 | 2014 | 223418 | 0.340 |
Why?
|
Islam | 1 | 2011 | 72 | 0.340 |
Why?
|
Topography, Medical | 2 | 2006 | 37 | 0.330 |
Why?
|
Brain Chemistry | 2 | 2005 | 962 | 0.330 |
Why?
|
Violence | 2 | 2007 | 937 | 0.330 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2010 | 57 | 0.330 |
Why?
|
Neuropsychiatry | 1 | 2010 | 76 | 0.330 |
Why?
|
Alcohol-Related Disorders | 1 | 2011 | 243 | 0.320 |
Why?
|
Vitamin D-Binding Protein | 1 | 2010 | 130 | 0.320 |
Why?
|
Substance-Related Disorders | 8 | 2013 | 4453 | 0.310 |
Why?
|
Exploratory Behavior | 8 | 2014 | 276 | 0.310 |
Why?
|
Speech Disorders | 1 | 2009 | 180 | 0.300 |
Why?
|
Dopamine | 7 | 2011 | 1616 | 0.300 |
Why?
|
Rats | 33 | 2014 | 23839 | 0.300 |
Why?
|
Social Adjustment | 2 | 2008 | 636 | 0.300 |
Why?
|
Age Distribution | 7 | 2013 | 2881 | 0.300 |
Why?
|
Health | 1 | 2011 | 399 | 0.300 |
Why?
|
Mothers | 2 | 2012 | 2210 | 0.290 |
Why?
|
Affective Symptoms | 2 | 2008 | 418 | 0.290 |
Why?
|
Hospitals, Psychiatric | 4 | 2005 | 318 | 0.290 |
Why?
|
Rats, Sprague-Dawley | 22 | 2014 | 8201 | 0.280 |
Why?
|
Life Change Events | 2 | 2010 | 964 | 0.280 |
Why?
|
Animals | 65 | 2014 | 169418 | 0.280 |
Why?
|
Cohort Studies | 24 | 2014 | 41797 | 0.280 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 436 | 0.280 |
Why?
|
Calcium Channel Blockers | 2 | 2001 | 692 | 0.280 |
Why?
|
Schizotypal Personality Disorder | 1 | 2008 | 289 | 0.270 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 6 | 2011 | 1994 | 0.270 |
Why?
|
Causality | 6 | 2010 | 1255 | 0.270 |
Why?
|
Cholinergic Agents | 3 | 2004 | 97 | 0.270 |
Why?
|
Calcium Signaling | 1 | 2011 | 737 | 0.270 |
Why?
|
Face | 2 | 2003 | 1031 | 0.270 |
Why?
|
Nucleus Accumbens | 2 | 2009 | 372 | 0.270 |
Why?
|
Hot Temperature | 3 | 2010 | 1439 | 0.270 |
Why?
|
Bipolar Disorder | 9 | 2011 | 5124 | 0.270 |
Why?
|
Vitamins | 2 | 2013 | 1638 | 0.260 |
Why?
|
Accidents | 1 | 2007 | 165 | 0.260 |
Why?
|
Neuropsychological Tests | 9 | 2010 | 7134 | 0.260 |
Why?
|
Memory Disorders | 2 | 2005 | 1204 | 0.260 |
Why?
|
Siblings | 1 | 2010 | 829 | 0.250 |
Why?
|
Interview, Psychological | 4 | 2012 | 812 | 0.250 |
Why?
|
Dizocilpine Maleate | 6 | 2013 | 173 | 0.250 |
Why?
|
Parturition | 3 | 2012 | 453 | 0.250 |
Why?
|
Parents | 3 | 2012 | 3596 | 0.250 |
Why?
|
Cross-Sectional Studies | 17 | 2013 | 26351 | 0.240 |
Why?
|
Gap Junctions | 1 | 2006 | 230 | 0.240 |
Why?
|
Mythology | 1 | 2005 | 15 | 0.240 |
Why?
|
Aged | 49 | 2013 | 171520 | 0.240 |
Why?
|
Longitudinal Studies | 10 | 2013 | 14766 | 0.240 |
Why?
|
Patient Admission | 4 | 2000 | 1370 | 0.240 |
Why?
|
Child | 32 | 2014 | 80863 | 0.240 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1134 | 0.240 |
Why?
|
Disease Outbreaks | 2 | 2010 | 1764 | 0.240 |
Why?
|
Parkinson Disease | 4 | 2013 | 2891 | 0.240 |
Why?
|
Parent-Child Relations | 1 | 2009 | 775 | 0.230 |
Why?
|
Geography | 3 | 2010 | 654 | 0.230 |
Why?
|
Calcium | 4 | 2012 | 5793 | 0.230 |
Why?
|
Malnutrition | 1 | 2010 | 632 | 0.230 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2011 | 3612 | 0.230 |
Why?
|
Disease Models, Animal | 21 | 2014 | 18388 | 0.220 |
Why?
|
Child Behavior | 1 | 2009 | 862 | 0.220 |
Why?
|
Models, Animal | 1 | 2010 | 2126 | 0.220 |
Why?
|
Child Behavior Disorders | 1 | 2008 | 813 | 0.220 |
Why?
|
Lithium Carbonate | 1 | 2004 | 179 | 0.210 |
Why?
|
Fetal Blood | 1 | 2010 | 1353 | 0.210 |
Why?
|
Hyperthermia, Induced | 2 | 2005 | 417 | 0.210 |
Why?
|
Hyperkinesis | 3 | 2007 | 88 | 0.210 |
Why?
|
Emigration and Immigration | 2 | 2005 | 405 | 0.210 |
Why?
|
Child, Preschool | 21 | 2014 | 42623 | 0.200 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 2046 | 0.200 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 1448 | 0.200 |
Why?
|
Community Mental Health Services | 3 | 2013 | 389 | 0.200 |
Why?
|
Gait Disorders, Neurologic | 1 | 2004 | 242 | 0.200 |
Why?
|
Social Support | 1 | 2012 | 2195 | 0.200 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2754 | 0.200 |
Why?
|
Smoking | 3 | 2012 | 9099 | 0.200 |
Why?
|
Climate | 1 | 2003 | 148 | 0.200 |
Why?
|
Chromatography, Gas | 1 | 2001 | 150 | 0.200 |
Why?
|
Bone and Bones | 1 | 2012 | 2589 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2011 | 16029 | 0.190 |
Why?
|
Corpus Striatum | 2 | 2013 | 1238 | 0.190 |
Why?
|
Cryoprotective Agents | 2 | 2006 | 128 | 0.190 |
Why?
|
Genetic Variation | 3 | 2011 | 6610 | 0.190 |
Why?
|
Models, Biological | 9 | 2013 | 9505 | 0.190 |
Why?
|
Aged, 80 and over | 19 | 2014 | 59680 | 0.190 |
Why?
|
Synapses | 1 | 2011 | 1766 | 0.190 |
Why?
|
Social Class | 4 | 2006 | 2000 | 0.190 |
Why?
|
Actins | 2 | 2006 | 2064 | 0.190 |
Why?
|
Poliomyelitis | 1 | 2002 | 92 | 0.190 |
Why?
|
Comorbidity | 10 | 2013 | 10601 | 0.190 |
Why?
|
Sunlight | 2 | 2007 | 337 | 0.190 |
Why?
|
Cardiography, Impedance | 1 | 2001 | 40 | 0.190 |
Why?
|
Vocabulary | 1 | 2002 | 167 | 0.190 |
Why?
|
Olfaction Disorders | 1 | 2004 | 226 | 0.190 |
Why?
|
Mesencephalon | 3 | 2013 | 339 | 0.180 |
Why?
|
Suicidal Ideation | 1 | 2011 | 1466 | 0.180 |
Why?
|
Culture | 1 | 2005 | 624 | 0.180 |
Why?
|
Odds Ratio | 7 | 2014 | 9687 | 0.180 |
Why?
|
Learning | 2 | 2007 | 1762 | 0.180 |
Why?
|
Pregnancy Complications | 6 | 2013 | 2969 | 0.180 |
Why?
|
Mood Disorders | 2 | 2003 | 1128 | 0.180 |
Why?
|
Locomotion | 2 | 2014 | 391 | 0.180 |
Why?
|
Family Health | 3 | 2011 | 1256 | 0.180 |
Why?
|
Social Environment | 3 | 2010 | 1026 | 0.180 |
Why?
|
Nerve Growth Factors | 3 | 2003 | 566 | 0.170 |
Why?
|
Maternal Exposure | 1 | 2007 | 1078 | 0.170 |
Why?
|
Crime Victims | 1 | 2004 | 347 | 0.170 |
Why?
|
Stress, Psychological | 4 | 2011 | 4538 | 0.170 |
Why?
|
Case-Control Studies | 15 | 2013 | 22293 | 0.170 |
Why?
|
Optics and Photonics | 1 | 2001 | 307 | 0.170 |
Why?
|
Mental Health Services | 6 | 2012 | 1732 | 0.170 |
Why?
|
Poverty | 1 | 2011 | 2719 | 0.170 |
Why?
|
GABA Modulators | 1 | 2000 | 109 | 0.170 |
Why?
|
Emotions | 1 | 2011 | 2773 | 0.170 |
Why?
|
Alcohol Drinking | 2 | 2011 | 4052 | 0.170 |
Why?
|
Craniofacial Abnormalities | 1 | 2002 | 320 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 4 | 2012 | 1734 | 0.160 |
Why?
|
Periodicity | 3 | 2007 | 348 | 0.160 |
Why?
|
Acoustic Stimulation | 5 | 2014 | 1253 | 0.160 |
Why?
|
Population Groups | 2 | 2010 | 208 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2000 | 167 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2004 | 717 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2002 | 412 | 0.160 |
Why?
|
Parkinsonian Disorders | 1 | 2002 | 285 | 0.160 |
Why?
|
Child Care | 1 | 1999 | 126 | 0.160 |
Why?
|
Autistic Disorder | 3 | 2013 | 1240 | 0.150 |
Why?
|
Marital Status | 2 | 2012 | 426 | 0.150 |
Why?
|
Health Status | 4 | 2012 | 4096 | 0.150 |
Why?
|
Abnormalities, Multiple | 2 | 2003 | 1424 | 0.150 |
Why?
|
Anti-Anxiety Agents | 2 | 2002 | 405 | 0.150 |
Why?
|
Amphetamine | 4 | 2013 | 224 | 0.150 |
Why?
|
Wounds and Injuries | 5 | 2012 | 2518 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2011 | 3794 | 0.140 |
Why?
|
Reaction Time | 7 | 2013 | 2102 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 10 | 2013 | 18048 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2008 | 2362 | 0.140 |
Why?
|
Infant | 15 | 2013 | 36497 | 0.140 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2009 | 3742 | 0.140 |
Why?
|
Mass Screening | 3 | 2010 | 5455 | 0.140 |
Why?
|
Analysis of Variance | 9 | 2012 | 6242 | 0.140 |
Why?
|
Thinking | 1 | 2000 | 320 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2014 | 39430 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2012 | 10784 | 0.140 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2011 | 452 | 0.140 |
Why?
|
Dependovirus | 1 | 2002 | 720 | 0.130 |
Why?
|
Substantia Nigra | 2 | 2013 | 348 | 0.130 |
Why?
|
Animals, Newborn | 8 | 2012 | 2696 | 0.130 |
Why?
|
Steroids | 1 | 2001 | 937 | 0.130 |
Why?
|
Community Health Planning | 3 | 2011 | 164 | 0.130 |
Why?
|
Head | 1 | 2002 | 927 | 0.130 |
Why?
|
Finland | 3 | 2008 | 609 | 0.130 |
Why?
|
Temperature | 4 | 2010 | 2237 | 0.130 |
Why?
|
Affect | 1 | 2004 | 1498 | 0.130 |
Why?
|
Age of Onset | 4 | 2012 | 3342 | 0.130 |
Why?
|
Mental Health | 2 | 2011 | 3271 | 0.130 |
Why?
|
Chromatography, Liquid | 2 | 2010 | 998 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3438 | 0.130 |
Why?
|
Benzodiazepines | 3 | 2003 | 1139 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4249 | 0.130 |
Why?
|
Fetal Nutrition Disorders | 2 | 2005 | 8 | 0.130 |
Why?
|
Awareness | 1 | 2000 | 654 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2013 | 12774 | 0.120 |
Why?
|
Heat-Shock Response | 1 | 1996 | 179 | 0.120 |
Why?
|
Early Diagnosis | 2 | 2012 | 1196 | 0.120 |
Why?
|
Brazil | 3 | 2007 | 1247 | 0.120 |
Why?
|
Risk | 5 | 2014 | 9642 | 0.120 |
Why?
|
Depressive Disorder, Major | 2 | 2010 | 4816 | 0.120 |
Why?
|
Academic Medical Centers | 1 | 2005 | 2785 | 0.120 |
Why?
|
Psychometrics | 3 | 2009 | 3072 | 0.120 |
Why?
|
Fertility | 1 | 1999 | 772 | 0.120 |
Why?
|
Sensory Gating | 1 | 2014 | 47 | 0.120 |
Why?
|
Meta-Analysis as Topic | 4 | 2012 | 1364 | 0.110 |
Why?
|
Swimming | 2 | 2005 | 209 | 0.110 |
Why?
|
Neoplasms | 3 | 2013 | 22386 | 0.110 |
Why?
|
Cell Line | 9 | 2011 | 15609 | 0.110 |
Why?
|
Developed Countries | 2 | 2007 | 451 | 0.110 |
Why?
|
Haloperidol | 5 | 2006 | 394 | 0.110 |
Why?
|
Confidence Intervals | 2 | 2014 | 2932 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2011 | 10358 | 0.110 |
Why?
|
Molecular Biology | 2 | 2005 | 573 | 0.110 |
Why?
|
Transients and Migrants | 2 | 2008 | 170 | 0.110 |
Why?
|
Influenza, Human | 2 | 1995 | 1540 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 2 | 2010 | 1197 | 0.110 |
Why?
|
Nonlinear Dynamics | 2 | 2007 | 496 | 0.110 |
Why?
|
Magnesium Chloride | 1 | 2012 | 30 | 0.110 |
Why?
|
Calibration | 2 | 2009 | 823 | 0.110 |
Why?
|
Phenotype | 11 | 2012 | 16712 | 0.110 |
Why?
|
Hemidesmosomes | 1 | 2012 | 5 | 0.110 |
Why?
|
Disability Evaluation | 2 | 2012 | 1839 | 0.110 |
Why?
|
Mice | 17 | 2012 | 82045 | 0.100 |
Why?
|
Vocational Education | 1 | 2012 | 4 | 0.100 |
Why?
|
Absorption | 1 | 2012 | 243 | 0.100 |
Why?
|
SOXF Transcription Factors | 1 | 2012 | 31 | 0.100 |
Why?
|
Epidermolysis Bullosa | 1 | 2012 | 29 | 0.100 |
Why?
|
Neural Inhibition | 3 | 2006 | 588 | 0.100 |
Why?
|
Rabbits | 3 | 2010 | 4786 | 0.100 |
Why?
|
Intelligence Tests | 1 | 2013 | 505 | 0.100 |
Why?
|
DNA | 1 | 2006 | 7213 | 0.100 |
Why?
|
Carbon Monoxide Poisoning | 2 | 1989 | 65 | 0.100 |
Why?
|
International Classification of Diseases | 4 | 2012 | 925 | 0.100 |
Why?
|
Risk Assessment | 6 | 2014 | 24311 | 0.100 |
Why?
|
Association | 1 | 2012 | 53 | 0.100 |
Why?
|
Interpersonal Relations | 2 | 2013 | 1439 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 390 | 0.100 |
Why?
|
Time Factors | 13 | 2013 | 40271 | 0.100 |
Why?
|
Breeding | 1 | 2011 | 51 | 0.090 |
Why?
|
Language Tests | 2 | 2009 | 193 | 0.090 |
Why?
|
History, 20th Century | 2 | 2013 | 2772 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14728 | 0.090 |
Why?
|
Memory | 3 | 2009 | 2210 | 0.090 |
Why?
|
Carbamates | 1 | 2012 | 192 | 0.090 |
Why?
|
Urine | 1 | 2012 | 363 | 0.090 |
Why?
|
Influenza A virus | 1 | 1994 | 460 | 0.090 |
Why?
|
Mortality | 3 | 2012 | 2917 | 0.090 |
Why?
|
Psychological Tests | 1 | 2013 | 643 | 0.090 |
Why?
|
Congenital Abnormalities | 1 | 1995 | 708 | 0.090 |
Why?
|
Glutaral | 1 | 2010 | 78 | 0.090 |
Why?
|
Acidosis | 1 | 2012 | 271 | 0.090 |
Why?
|
Models, Genetic | 2 | 2011 | 3442 | 0.090 |
Why?
|
Prefrontal Cortex | 3 | 2013 | 2251 | 0.090 |
Why?
|
Spermatozoa | 2 | 2013 | 631 | 0.090 |
Why?
|
Psychotherapy | 1 | 1999 | 1656 | 0.090 |
Why?
|
History, 19th Century | 1 | 2013 | 716 | 0.090 |
Why?
|
Sound Localization | 1 | 2010 | 62 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2004 | 3826 | 0.090 |
Why?
|
Starvation | 1 | 2010 | 141 | 0.090 |
Why?
|
Cost of Illness | 2 | 2010 | 1960 | 0.090 |
Why?
|
Sweden | 3 | 2013 | 1382 | 0.090 |
Why?
|
Data Collection | 3 | 2007 | 3329 | 0.090 |
Why?
|
GABA Agonists | 2 | 2001 | 104 | 0.090 |
Why?
|
Genotype | 6 | 2010 | 13047 | 0.090 |
Why?
|
Folic Acid Deficiency | 1 | 2010 | 117 | 0.080 |
Why?
|
Forecasting | 3 | 2007 | 2950 | 0.080 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2013 | 395 | 0.080 |
Why?
|
Psychotropic Drugs | 2 | 2013 | 888 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2011 | 15965 | 0.080 |
Why?
|
Heating | 1 | 2010 | 104 | 0.080 |
Why?
|
Solutions | 1 | 2010 | 411 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 2012 | 437 | 0.080 |
Why?
|
Cause of Death | 2 | 2012 | 3727 | 0.080 |
Why?
|
Acrocallosal Syndrome | 1 | 2009 | 1 | 0.080 |
Why?
|
Puberty | 2 | 2013 | 502 | 0.080 |
Why?
|
Ultrasonics | 1 | 2010 | 208 | 0.080 |
Why?
|
Radioimmunoassay | 1 | 2010 | 862 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 9507 | 0.080 |
Why?
|
Aging | 5 | 2012 | 8761 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2010 | 2119 | 0.080 |
Why?
|
Signal Transduction | 10 | 2013 | 23638 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2010 | 1543 | 0.080 |
Why?
|
Space Perception | 2 | 2003 | 467 | 0.080 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2007 | 4636 | 0.080 |
Why?
|
Symbiosis | 1 | 2011 | 297 | 0.080 |
Why?
|
Fibroblasts | 3 | 2011 | 4180 | 0.080 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2010 | 264 | 0.080 |
Why?
|
Preservation, Biological | 1 | 1988 | 26 | 0.080 |
Why?
|
Skin Pigmentation | 1 | 2011 | 278 | 0.080 |
Why?
|
Maze Learning | 3 | 2005 | 484 | 0.080 |
Why?
|
Jews | 1 | 2010 | 358 | 0.080 |
Why?
|
Nervous System Diseases | 2 | 2011 | 1668 | 0.080 |
Why?
|
Attention | 4 | 2012 | 2423 | 0.080 |
Why?
|
Socioeconomic Factors | 4 | 2012 | 7863 | 0.080 |
Why?
|
Neural Stem Cells | 2 | 2013 | 892 | 0.080 |
Why?
|
Marijuana Smoking | 1 | 2011 | 259 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 284 | 0.080 |
Why?
|
Nerve Growth Factor | 3 | 2005 | 157 | 0.070 |
Why?
|
Prospective Studies | 8 | 2012 | 54914 | 0.070 |
Why?
|
Restraint, Physical | 2 | 2006 | 185 | 0.070 |
Why?
|
Respiratory Mucosa | 1 | 2011 | 439 | 0.070 |
Why?
|
Neurosciences | 1 | 2013 | 385 | 0.070 |
Why?
|
Nervous System Malformations | 2 | 2003 | 244 | 0.070 |
Why?
|
Health Services Needs and Demand | 2 | 2014 | 1408 | 0.070 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 494 | 0.070 |
Why?
|
Cytoplasm | 1 | 2012 | 1503 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 1996 | 1898 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2488 | 0.070 |
Why?
|
Cell Membrane | 1 | 1997 | 3664 | 0.070 |
Why?
|
Ovum | 1 | 1988 | 187 | 0.070 |
Why?
|
Poisoning | 1 | 1989 | 252 | 0.070 |
Why?
|
Random Allocation | 3 | 2012 | 2399 | 0.070 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 419 | 0.070 |
Why?
|
Cross-Linking Reagents | 1 | 2010 | 692 | 0.070 |
Why?
|
Rural Population | 2 | 2010 | 2317 | 0.070 |
Why?
|
Activities of Daily Living | 3 | 2012 | 2433 | 0.070 |
Why?
|
Embryo, Mammalian | 2 | 2011 | 1674 | 0.070 |
Why?
|
Prosencephalon | 1 | 2009 | 306 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15638 | 0.070 |
Why?
|
Reference Values | 5 | 2008 | 4941 | 0.070 |
Why?
|
Thoracic Wall | 1 | 2009 | 204 | 0.070 |
Why?
|
Vinculin | 1 | 2006 | 59 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1915 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3830 | 0.070 |
Why?
|
Sensory Receptor Cells | 1 | 2011 | 508 | 0.070 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 828 | 0.070 |
Why?
|
Apoptosis | 4 | 2011 | 9526 | 0.070 |
Why?
|
Mice, Inbred C57BL | 8 | 2012 | 22365 | 0.070 |
Why?
|
Mass Spectrometry | 2 | 2013 | 2204 | 0.070 |
Why?
|
Logistic Models | 5 | 2013 | 13324 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 506 | 0.070 |
Why?
|
Hospitals, Public | 1 | 1988 | 205 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2007 | 509 | 0.070 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2010 | 373 | 0.070 |
Why?
|
Population Surveillance | 3 | 2014 | 2601 | 0.070 |
Why?
|
Memory, Short-Term | 2 | 2003 | 1009 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2010 | 835 | 0.060 |
Why?
|
Patient Readmission | 1 | 2000 | 3308 | 0.060 |
Why?
|
Psychiatry | 3 | 1998 | 1714 | 0.060 |
Why?
|
Menarche | 1 | 2009 | 538 | 0.060 |
Why?
|
Developing Countries | 2 | 2010 | 2901 | 0.060 |
Why?
|
Bacteria | 2 | 2011 | 2226 | 0.060 |
Why?
|
Insanity Defense | 1 | 1985 | 28 | 0.060 |
Why?
|
Feces | 1 | 2012 | 1515 | 0.060 |
Why?
|
Connexin 43 | 1 | 2006 | 202 | 0.060 |
Why?
|
Organic Chemicals | 1 | 2006 | 211 | 0.060 |
Why?
|
Disease | 1 | 2011 | 673 | 0.060 |
Why?
|
Zambia | 1 | 2006 | 273 | 0.060 |
Why?
|
American Medical Association | 1 | 1985 | 60 | 0.060 |
Why?
|
Pyridinium Compounds | 2 | 1996 | 81 | 0.060 |
Why?
|
Trail Making Test | 1 | 2005 | 57 | 0.060 |
Why?
|
Epigenomics | 1 | 2011 | 956 | 0.060 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1561 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2010 | 2342 | 0.060 |
Why?
|
New Zealand | 3 | 2013 | 360 | 0.060 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 66 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 472 | 0.060 |
Why?
|
Somatomedins | 1 | 2005 | 179 | 0.060 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1032 | 0.060 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2004 | 24 | 0.060 |
Why?
|
Waist Circumference | 3 | 2013 | 935 | 0.060 |
Why?
|
Reflex, Acoustic | 1 | 2004 | 34 | 0.060 |
Why?
|
Body Weights and Measures | 1 | 2005 | 208 | 0.060 |
Why?
|
Dermis | 1 | 2006 | 204 | 0.060 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 738 | 0.060 |
Why?
|
Pilot Projects | 4 | 2006 | 8730 | 0.060 |
Why?
|
Depressive Disorder | 3 | 2008 | 3738 | 0.060 |
Why?
|
Sex Ratio | 1 | 2005 | 107 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 960 | 0.060 |
Why?
|
Habituation, Psychophysiologic | 1 | 2005 | 148 | 0.060 |
Why?
|
Mental Recall | 1 | 2010 | 1226 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 940 | 0.060 |
Why?
|
Body Constitution | 1 | 2004 | 273 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2010 | 1479 | 0.060 |
Why?
|
Forensic Psychiatry | 1 | 1985 | 198 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2011 | 10494 | 0.060 |
Why?
|
Lymphocytes | 2 | 2010 | 2611 | 0.060 |
Why?
|
Intelligence | 1 | 2009 | 929 | 0.060 |
Why?
|
Visual Perception | 2 | 2003 | 1406 | 0.060 |
Why?
|
Fetus | 1 | 2011 | 1883 | 0.060 |
Why?
|
Ethics, Medical | 1 | 1989 | 785 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2011 | 11674 | 0.050 |
Why?
|
Respiratory Tract Infections | 1 | 2011 | 1013 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2005 | 9182 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1660 | 0.050 |
Why?
|
Aggression | 1 | 2008 | 750 | 0.050 |
Why?
|
Triazoles | 1 | 2009 | 905 | 0.050 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2004 | 161 | 0.050 |
Why?
|
Polymerase Chain Reaction | 4 | 2008 | 6091 | 0.050 |
Why?
|
Suicide, Attempted | 1 | 2012 | 1409 | 0.050 |
Why?
|
Time | 1 | 2005 | 546 | 0.050 |
Why?
|
Antioxidants | 1 | 2011 | 1678 | 0.050 |
Why?
|
Medicine in Literature | 1 | 2003 | 32 | 0.050 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 937 | 0.050 |
Why?
|
Patient Participation | 1 | 2012 | 1450 | 0.050 |
Why?
|
Nutrition Policy | 1 | 2007 | 467 | 0.050 |
Why?
|
Pirenzepine | 1 | 2003 | 116 | 0.050 |
Why?
|
Wnt Proteins | 1 | 2007 | 724 | 0.050 |
Why?
|
Qualitative Research | 1 | 2014 | 3115 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2013 | 81834 | 0.050 |
Why?
|
Olfactory Pathways | 1 | 2004 | 133 | 0.050 |
Why?
|
Placental Insufficiency | 1 | 2003 | 50 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2004 | 882 | 0.050 |
Why?
|
Tensile Strength | 1 | 2003 | 335 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2009 | 65409 | 0.050 |
Why?
|
Rural Health | 1 | 2004 | 300 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2004 | 377 | 0.050 |
Why?
|
Body Size | 1 | 2005 | 463 | 0.050 |
Why?
|
Remission Induction | 1 | 2008 | 2408 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6537 | 0.050 |
Why?
|
Depression | 2 | 2013 | 8235 | 0.050 |
Why?
|
Recovery of Function | 1 | 2012 | 2994 | 0.050 |
Why?
|
Rats, Inbred F344 | 2 | 2002 | 826 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2006 | 705 | 0.050 |
Why?
|
Protein Array Analysis | 1 | 2004 | 399 | 0.050 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 2 | 2013 | 63 | 0.050 |
Why?
|
Apomorphine | 1 | 2002 | 150 | 0.050 |
Why?
|
Proteins | 2 | 2007 | 6008 | 0.050 |
Why?
|
Medial Forebrain Bundle | 1 | 2002 | 43 | 0.050 |
Why?
|
Alleles | 4 | 2008 | 6890 | 0.050 |
Why?
|
Oxidopamine | 1 | 2002 | 173 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2009 | 1514 | 0.050 |
Why?
|
Survival Analysis | 2 | 2013 | 10125 | 0.050 |
Why?
|
Smell | 1 | 2004 | 261 | 0.050 |
Why?
|
Patient Dropouts | 1 | 2004 | 411 | 0.050 |
Why?
|
Research Design | 2 | 2008 | 6217 | 0.050 |
Why?
|
Urban Health | 1 | 2004 | 535 | 0.050 |
Why?
|
Elasticity | 1 | 2003 | 658 | 0.050 |
Why?
|
Paraplegia | 1 | 2002 | 161 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 1998 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2585 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2012 | 11930 | 0.050 |
Why?
|
Brain Diseases | 1 | 2010 | 1553 | 0.050 |
Why?
|
Neurites | 1 | 2003 | 391 | 0.050 |
Why?
|
Public Policy | 1 | 2005 | 560 | 0.050 |
Why?
|
Dementia | 1 | 1995 | 2723 | 0.050 |
Why?
|
Skin | 2 | 2012 | 4520 | 0.050 |
Why?
|
Haplotypes | 2 | 2006 | 2725 | 0.050 |
Why?
|
Risperidone | 1 | 2003 | 383 | 0.050 |
Why?
|
Obesity | 2 | 2013 | 13065 | 0.050 |
Why?
|
Evoked Potentials, Auditory | 1 | 2004 | 533 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2003 | 583 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2003 | 533 | 0.050 |
Why?
|
Monoamine Oxidase | 2 | 2012 | 183 | 0.040 |
Why?
|
Vitamin A | 1 | 2004 | 611 | 0.040 |
Why?
|
Social Behavior | 3 | 2013 | 1144 | 0.040 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2002 | 370 | 0.040 |
Why?
|
Homozygote | 2 | 2012 | 1779 | 0.040 |
Why?
|
Psychomotor Disorders | 1 | 2001 | 149 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2012 | 2181 | 0.040 |
Why?
|
Semantics | 1 | 2004 | 617 | 0.040 |
Why?
|
Schizophrenic Language | 1 | 2000 | 57 | 0.040 |
Why?
|
Nimodipine | 1 | 2000 | 57 | 0.040 |
Why?
|
Health Promotion | 1 | 2012 | 2215 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2007 | 1734 | 0.040 |
Why?
|
Child Custody | 1 | 1999 | 20 | 0.040 |
Why?
|
Multiple Sclerosis | 2 | 2012 | 3245 | 0.040 |
Why?
|
Fingers | 1 | 2003 | 511 | 0.040 |
Why?
|
Geologic Sediments | 1 | 2000 | 82 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 712 | 0.040 |
Why?
|
Hormones | 1 | 2004 | 870 | 0.040 |
Why?
|
Extremities | 1 | 2005 | 870 | 0.040 |
Why?
|
Cell Division | 3 | 2006 | 4479 | 0.040 |
Why?
|
Diet | 4 | 2012 | 8098 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2096 | 0.040 |
Why?
|
Thalamus | 1 | 2006 | 1051 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4572 | 0.040 |
Why?
|
Child Development | 1 | 2011 | 2328 | 0.040 |
Why?
|
Genes, Lethal | 1 | 1980 | 223 | 0.040 |
Why?
|
Diltiazem | 1 | 2000 | 132 | 0.040 |
Why?
|
Nifedipine | 1 | 2000 | 220 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 1989 | 1677 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12561 | 0.040 |
Why?
|
Gait | 1 | 2005 | 822 | 0.040 |
Why?
|
Verapamil | 1 | 2000 | 242 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2010 | 5308 | 0.040 |
Why?
|
Femur | 1 | 2005 | 1311 | 0.040 |
Why?
|
Catechol O-Methyltransferase | 2 | 2012 | 251 | 0.040 |
Why?
|
Needs Assessment | 1 | 2005 | 1146 | 0.040 |
Why?
|
History, 21st Century | 1 | 2005 | 1575 | 0.040 |
Why?
|
Perceptual Disorders | 1 | 2001 | 199 | 0.040 |
Why?
|
Cell Death | 2 | 2006 | 1684 | 0.040 |
Why?
|
Chronic Disease | 4 | 2010 | 9382 | 0.040 |
Why?
|
Nicotine | 1 | 2004 | 681 | 0.040 |
Why?
|
Family Practice | 1 | 2001 | 510 | 0.040 |
Why?
|
Acute Disease | 2 | 2001 | 7246 | 0.040 |
Why?
|
Heat-Shock Proteins | 2 | 2007 | 798 | 0.040 |
Why?
|
Mental Processes | 1 | 2000 | 247 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2003 | 542 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2003 | 1680 | 0.040 |
Why?
|
Porphyrias | 1 | 1998 | 57 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4655 | 0.040 |
Why?
|
Mitosis | 1 | 2003 | 1191 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4029 | 0.040 |
Why?
|
Interneurons | 1 | 2002 | 592 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1085 | 0.040 |
Why?
|
Hand | 1 | 2003 | 907 | 0.040 |
Why?
|
Osteoporosis | 2 | 2012 | 1606 | 0.040 |
Why?
|
Prenatal Care | 1 | 2005 | 1159 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2000 | 839 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2003 | 1057 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2649 | 0.040 |
Why?
|
Netherlands | 1 | 2002 | 2274 | 0.030 |
Why?
|
Choice Behavior | 2 | 2013 | 846 | 0.030 |
Why?
|
Sleep | 1 | 2013 | 4796 | 0.030 |
Why?
|
Computer Simulation | 3 | 2005 | 6278 | 0.030 |
Why?
|
Laughter | 1 | 1996 | 19 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 1998 | 173 | 0.030 |
Why?
|
Hippocampus | 3 | 2006 | 3783 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2006 | 19041 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2003 | 1315 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2003 | 2103 | 0.030 |
Why?
|
Collagen | 1 | 2005 | 2646 | 0.030 |
Why?
|
Crying | 1 | 1996 | 37 | 0.030 |
Why?
|
Suicide | 1 | 2007 | 1608 | 0.030 |
Why?
|
Functional Laterality | 1 | 2003 | 2268 | 0.030 |
Why?
|
Knee Joint | 1 | 2005 | 1683 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2002 | 801 | 0.030 |
Why?
|
National Health Programs | 2 | 2014 | 442 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2002 | 1136 | 0.030 |
Why?
|
Heart | 1 | 1989 | 4451 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1998 | 412 | 0.030 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11138 | 0.030 |
Why?
|
Gene Frequency | 3 | 2010 | 3615 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2003 | 4861 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 1996 | 266 | 0.030 |
Why?
|
Famotidine | 1 | 1995 | 17 | 0.030 |
Why?
|
Species Specificity | 2 | 2012 | 2422 | 0.030 |
Why?
|
Dopamine Antagonists | 1 | 1996 | 289 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2010 | 1869 | 0.030 |
Why?
|
Remoxipride | 1 | 1994 | 2 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2005 | 2847 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2001 | 997 | 0.030 |
Why?
|
Thioridazine | 1 | 1994 | 33 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2889 | 0.030 |
Why?
|
Leukopenia | 1 | 1995 | 214 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12875 | 0.030 |
Why?
|
Zidovudine | 1 | 1996 | 625 | 0.030 |
Why?
|
Bromodeoxyuridine | 2 | 2005 | 310 | 0.030 |
Why?
|
Calcitriol | 2 | 2007 | 303 | 0.030 |
Why?
|
Biopsy | 3 | 2006 | 6816 | 0.030 |
Why?
|
Interleukin-3 | 1 | 1995 | 425 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1996 | 595 | 0.030 |
Why?
|
Prognosis | 2 | 2012 | 30028 | 0.030 |
Why?
|
Hospitalization | 4 | 2012 | 10845 | 0.030 |
Why?
|
Pedigree | 2 | 2012 | 4545 | 0.030 |
Why?
|
Helplessness, Learned | 1 | 2013 | 28 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6320 | 0.030 |
Why?
|
Carcinoma, Lobular | 1 | 1998 | 480 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1996 | 631 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2010 | 5827 | 0.030 |
Why?
|
Mitochondria | 1 | 2006 | 3672 | 0.030 |
Why?
|
Social Isolation | 2 | 2010 | 369 | 0.030 |
Why?
|
Societies, Medical | 1 | 1985 | 3955 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2006 | 4948 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1999 | 3103 | 0.030 |
Why?
|
Nervous System | 1 | 1996 | 547 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2004 | 12096 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1189 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 14158 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2003 | 12450 | 0.030 |
Why?
|
Birth Order | 1 | 2013 | 95 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2010 | 20231 | 0.030 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2012 | 76 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2005 | 14480 | 0.030 |
Why?
|
HMGB Proteins | 1 | 2012 | 45 | 0.030 |
Why?
|
India | 2 | 2012 | 2323 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 129 | 0.030 |
Why?
|
G2 Phase | 1 | 1993 | 136 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2089 | 0.030 |
Why?
|
Carboxyhemoglobin | 2 | 1989 | 83 | 0.030 |
Why?
|
Health Planning | 1 | 2014 | 233 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 185 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2013 | 1140 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
Bone Density | 1 | 2005 | 3561 | 0.030 |
Why?
|
Cyclin A2 | 1 | 2011 | 21 | 0.020 |
Why?
|
Sibling Relations | 1 | 1992 | 46 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2013 | 259 | 0.020 |
Why?
|
Malaysia | 1 | 2012 | 107 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 4362 | 0.020 |
Why?
|
Burns | 1 | 2003 | 1887 | 0.020 |
Why?
|
Glutamate Decarboxylase | 1 | 2012 | 239 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 13655 | 0.020 |
Why?
|
Catecholamines | 1 | 2012 | 390 | 0.020 |
Why?
|
Sunbathing | 1 | 2012 | 66 | 0.020 |
Why?
|
Neuroanatomy | 1 | 2012 | 73 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15460 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10865 | 0.020 |
Why?
|
Body Fat Distribution | 1 | 2013 | 245 | 0.020 |
Why?
|
Eye Diseases | 1 | 1997 | 657 | 0.020 |
Why?
|
Cyclin E | 1 | 2011 | 156 | 0.020 |
Why?
|
Occupations | 1 | 1993 | 519 | 0.020 |
Why?
|
Birth Injuries | 1 | 2012 | 151 | 0.020 |
Why?
|
Hydroxycholecalciferols | 1 | 2010 | 44 | 0.020 |
Why?
|
Body Mass Index | 3 | 2013 | 13030 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2012 | 279 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 735 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9425 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1092 | 0.020 |
Why?
|
Hemodynamics | 1 | 2001 | 4202 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4984 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2012 | 1876 | 0.020 |
Why?
|
Toxoplasma | 1 | 2011 | 159 | 0.020 |
Why?
|
Fathers | 1 | 2013 | 377 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2011 | 191 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 1996 | 821 | 0.020 |
Why?
|
Genetic Markers | 1 | 1996 | 2604 | 0.020 |
Why?
|
Homovanillic Acid | 1 | 2009 | 75 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2011 | 454 | 0.020 |
Why?
|
Peru | 1 | 2012 | 894 | 0.020 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2009 | 94 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2012 | 1770 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
Mastectomy, Modified Radical | 1 | 2009 | 62 | 0.020 |
Why?
|
Clozapine | 1 | 2012 | 508 | 0.020 |
Why?
|
Adjustment Disorders | 1 | 1989 | 68 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 453 | 0.020 |
Why?
|
Lymphatic Irradiation | 1 | 2009 | 115 | 0.020 |
Why?
|
Osmosis | 1 | 1988 | 103 | 0.020 |
Why?
|
Altitude Sickness | 1 | 1989 | 92 | 0.020 |
Why?
|
Blood Glucose | 2 | 2013 | 6429 | 0.020 |
Why?
|
Walking | 1 | 1996 | 1202 | 0.020 |
Why?
|
Exons | 2 | 2008 | 2392 | 0.020 |
Why?
|
HIV-1 | 2 | 1996 | 6966 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2009 | 391 | 0.020 |
Why?
|
Manuals as Topic | 1 | 1988 | 99 | 0.020 |
Why?
|
Tanzania | 1 | 2012 | 1405 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1989 | 2087 | 0.020 |
Why?
|
Tasmania | 1 | 2007 | 4 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2011 | 993 | 0.020 |
Why?
|
Hematocrit | 1 | 1989 | 625 | 0.020 |
Why?
|
Observation | 1 | 2009 | 311 | 0.020 |
Why?
|
Arousal | 1 | 1993 | 1182 | 0.020 |
Why?
|
Freezing | 1 | 1988 | 311 | 0.020 |
Why?
|
Maryland | 1 | 1988 | 277 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 1855 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2143 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 2944 | 0.020 |
Why?
|
Probability | 1 | 2012 | 2483 | 0.020 |
Why?
|
Unemployment | 1 | 1989 | 210 | 0.020 |
Why?
|
Workplace | 1 | 1993 | 872 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1820 | 0.020 |
Why?
|
Twin Studies as Topic | 1 | 2007 | 103 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2011 | 755 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 21156 | 0.020 |
Why?
|
United States | 3 | 2012 | 73121 | 0.020 |
Why?
|
Thermodynamics | 1 | 1988 | 594 | 0.020 |
Why?
|
Cardiac Output | 1 | 1989 | 838 | 0.020 |
Why?
|
Genetics, Population | 1 | 2011 | 946 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2008 | 1305 | 0.020 |
Why?
|
Norepinephrine | 1 | 2009 | 900 | 0.020 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2006 | 60 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 1988 | 574 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1173 | 0.020 |
Why?
|
Reproduction | 1 | 2011 | 646 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1538 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2437 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 905 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2011 | 744 | 0.020 |
Why?
|
Cycloheximide | 1 | 2006 | 343 | 0.020 |
Why?
|
Mutation | 3 | 2013 | 30243 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2465 | 0.020 |
Why?
|
China | 1 | 2012 | 2398 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 797 | 0.020 |
Why?
|
Gender Identity | 1 | 1992 | 769 | 0.020 |
Why?
|
Mitotic Index | 1 | 2006 | 164 | 0.020 |
Why?
|
HIV Core Protein p24 | 2 | 1996 | 247 | 0.020 |
Why?
|
Corticosterone | 1 | 2006 | 302 | 0.020 |
Why?
|
Organogenesis | 1 | 2007 | 214 | 0.020 |
Why?
|
Communication | 1 | 2000 | 3910 | 0.020 |
Why?
|
Thermal Conductivity | 1 | 2005 | 16 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2005 | 63 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5042 | 0.020 |
Why?
|
Genetics, Behavioral | 1 | 2005 | 53 | 0.020 |
Why?
|
Blood Pressure | 2 | 2012 | 8538 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2005 | 118 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2863 | 0.010 |
Why?
|
Phosphatidylinositols | 1 | 2006 | 280 | 0.010 |
Why?
|
Blood Cell Count | 2 | 1996 | 402 | 0.010 |
Why?
|
Th1 Cells | 1 | 2010 | 1044 | 0.010 |
Why?
|
Organ Size | 1 | 2010 | 2268 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 2008 | 5803 | 0.010 |
Why?
|
Cricetinae | 1 | 1988 | 2423 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2007 | 462 | 0.010 |
Why?
|
Immune System | 1 | 2010 | 801 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 2006 | 309 | 0.010 |
Why?
|
Psychomotor Performance | 2 | 2003 | 1894 | 0.010 |
Why?
|
Serotonin | 1 | 2009 | 1047 | 0.010 |
Why?
|
Lactoglobulins | 1 | 1983 | 22 | 0.010 |
Why?
|
Neoplasm Staging | 3 | 2009 | 11249 | 0.010 |
Why?
|
Diffusion | 1 | 2006 | 818 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2005 | 145 | 0.010 |
Why?
|
Immunoglobulin A, Secretory | 1 | 1983 | 105 | 0.010 |
Why?
|
Fiji | 1 | 2003 | 47 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1996 | 3063 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1553 | 0.010 |
Why?
|
Caspase 3 | 1 | 2006 | 732 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1989 | 1009 | 0.010 |
Why?
|
Disabled Persons | 1 | 2013 | 1218 | 0.010 |
Why?
|
Roman World | 1 | 2003 | 3 | 0.010 |
Why?
|
Greek World | 1 | 2003 | 6 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6241 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1794 | 0.010 |
Why?
|
Leprosy | 1 | 1983 | 126 | 0.010 |
Why?
|
Phosphates | 1 | 2007 | 767 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2005 | 796 | 0.010 |
Why?
|
Lactoferrin | 1 | 1983 | 100 | 0.010 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2003 | 48 | 0.010 |
Why?
|
Fear | 1 | 2012 | 1494 | 0.010 |
Why?
|
Genetic Engineering | 1 | 1989 | 936 | 0.010 |
Why?
|
Cell Survival | 2 | 2005 | 5801 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1989 | 1617 | 0.010 |
Why?
|
Treatment Failure | 2 | 2000 | 2656 | 0.010 |
Why?
|
Systems Biology | 1 | 2006 | 481 | 0.010 |
Why?
|
Caspases | 1 | 2006 | 884 | 0.010 |
Why?
|
Tumor Burden | 1 | 2009 | 1909 | 0.010 |
Why?
|
History, Ancient | 1 | 2003 | 215 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 2005 | 265 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1989 | 1882 | 0.010 |
Why?
|
Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
Connective Tissue | 1 | 2005 | 425 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2007 | 764 | 0.010 |
Why?
|
Radiotherapy Dosage | 2 | 2000 | 2925 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 2127 | 0.010 |
Why?
|
Water | 1 | 1988 | 1421 | 0.010 |
Why?
|
Tubulin | 1 | 2005 | 695 | 0.010 |
Why?
|
Recurrence | 2 | 1998 | 8510 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5426 | 0.010 |
Why?
|
Alcohol Deterrents | 1 | 2002 | 49 | 0.010 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2003 | 200 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1421 | 0.010 |
Why?
|
Models, Statistical | 1 | 1996 | 5103 | 0.010 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2002 | 303 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3346 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2930 | 0.010 |
Why?
|
Albumins | 1 | 1983 | 578 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2006 | 761 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5223 | 0.010 |
Why?
|
Photobiology | 1 | 2000 | 10 | 0.010 |
Why?
|
Siberia | 1 | 2000 | 30 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2013 | 3202 | 0.010 |
Why?
|
Receptors, GABA-A | 1 | 2005 | 626 | 0.010 |
Why?
|
Mastectomy | 1 | 2009 | 1852 | 0.010 |
Why?
|
Liver | 1 | 1996 | 7575 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3123 | 0.010 |
Why?
|
Light | 1 | 2006 | 1357 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2005 | 12813 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 1804 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2000 | 228 | 0.010 |
Why?
|
Breast | 1 | 2009 | 1976 | 0.010 |
Why?
|
Verbal Learning | 1 | 2002 | 465 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9558 | 0.010 |
Why?
|
Atrophy | 1 | 2005 | 1648 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1078 | 0.010 |
Why?
|
Ice | 1 | 2000 | 102 | 0.010 |
Why?
|
HIV Infections | 2 | 1996 | 17564 | 0.010 |
Why?
|
Milk, Human | 1 | 1983 | 489 | 0.010 |
Why?
|
Genitalia, Female | 1 | 1980 | 146 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 1999 | 296 | 0.010 |
Why?
|
Protoporphyrinogen Oxidase | 1 | 1998 | 3 | 0.010 |
Why?
|
Sperm Motility | 1 | 1980 | 266 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6856 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1998 | 46 | 0.010 |
Why?
|
Flavoproteins | 1 | 1998 | 40 | 0.010 |
Why?
|
Body Weight | 2 | 2005 | 4630 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4586 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6527 | 0.010 |
Why?
|
Public Opinion | 1 | 1982 | 487 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2260 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36840 | 0.010 |
Why?
|
Heart Rate | 1 | 1989 | 4218 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2425 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1998 | 612 | 0.010 |
Why?
|
Narcotic Antagonists | 1 | 2002 | 590 | 0.010 |
Why?
|
Olfactory Marker Protein | 1 | 1996 | 12 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1998 | 218 | 0.010 |
Why?
|
Electroconvulsive Therapy | 1 | 1982 | 502 | 0.010 |
Why?
|
Cold Temperature | 1 | 2000 | 786 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 1996 | 148 | 0.010 |
Why?
|
Culture Media | 1 | 1998 | 899 | 0.010 |
Why?
|
Myocardium | 1 | 1989 | 4788 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 2002 | 825 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2000 | 13589 | 0.010 |
Why?
|
Electrocardiography | 1 | 1989 | 6410 | 0.010 |
Why?
|
Ecosystem | 1 | 2000 | 494 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2003 | 1539 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1995 | 88 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5904 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1996 | 527 | 0.010 |
Why?
|
Los Angeles | 1 | 1996 | 245 | 0.010 |
Why?
|
Hospitals, State | 1 | 1995 | 28 | 0.010 |
Why?
|
Length of Stay | 1 | 1989 | 6521 | 0.010 |
Why?
|
Drug Costs | 1 | 2003 | 1196 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7449 | 0.010 |
Why?
|
Hospitals, Private | 1 | 1995 | 67 | 0.010 |
Why?
|
Language | 1 | 2004 | 1557 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2000 | 2072 | 0.010 |
Why?
|
Genome, Human | 1 | 2007 | 4453 | 0.010 |
Why?
|
Epithelium | 1 | 1998 | 1610 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2000 | 1159 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3697 | 0.010 |
Why?
|
Diffusion of Innovation | 1 | 1998 | 730 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2006 | 7599 | 0.010 |
Why?
|
Cell Polarity | 1 | 1996 | 639 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1998 | 1014 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1999 | 2640 | 0.010 |
Why?
|
Phylogeny | 1 | 2000 | 2846 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5808 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 5767 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1995 | 20762 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 1998 | 979 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1996 | 1053 | 0.010 |
Why?
|
Cell Count | 1 | 1996 | 1835 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1998 | 2232 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 1980 | 1297 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7605 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1994 | 916 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2003 | 5532 | 0.010 |
Why?
|
Trauma Centers | 1 | 1996 | 950 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3538 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9623 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8559 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11843 | 0.000 |
Why?
|
Transcription Factors | 1 | 2007 | 12174 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12428 | 0.000 |
Why?
|
RNA, Viral | 1 | 1995 | 2865 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13452 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3122 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17647 | 0.000 |
Why?
|
Scotland | 1 | 1983 | 143 | 0.000 |
Why?
|
Attitude of Health Personnel | 1 | 1998 | 3922 | 0.000 |
Why?
|
Ethiopia | 1 | 1983 | 481 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 13026 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 1998 | 7451 | 0.000 |
Why?
|
Epidemiologic Methods | 1 | 1983 | 1337 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1989 | 3839 | 0.000 |
Why?
|
Postpartum Period | 1 | 1983 | 1197 | 0.000 |
Why?
|
Patient Education as Topic | 1 | 1982 | 2339 | 0.000 |
Why?
|
Patient Acceptance of Health Care | 1 | 1982 | 3237 | 0.000 |
Why?
|